Adial Pharmaceuticals Q2 EPS $(11.25)
Share
Why It Matters
Adial Pharmaceuticals lost a lot of money in the last three months—way more than they made. When a company loses this much money, it means they're burning through their savings fast, so watch if they can find a way to make money soon or get more funding.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.